Form D · Biotechnology
SEMBIOSYS GENETICS INC
Calgary, A0 · CIK 0001128323
Offering snapshot reported Mar 26, 2010 · SEC filing
- Reported sold
- $88.7K Offering amount: $88.7K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 12, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 26, 2010 | Initial | $88,651 | No comparison | 2 | SEC filing |
| Mar 31, 2009 | Initial | $43,501 | No comparison | Not reported | SEC filing |
| Jan 4, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-72102
Source: Form D, filed Mar 26, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ian Brown | Director |
| Dean Brown | Executive |
| Alexander Giaquinto | Director |
| Bruce Given | Executive |
| Nancy Harrison | Director |
| David Howard | Director |
| Maurice Moloney | Executive |
| Oye Olukotun | Director |
| William Smith | Director |
| Richard Smith | Director |
| James Szarko | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
#110, 2985 23rd Avenue Ne
Calgary, A0, T1Y7L3
Calgary, A0, T1Y7L3